Page last updated: 2024-10-21

hydroxyindoleacetic acid and Chronic Fatigue and Immune Dysfunction Syndrome

hydroxyindoleacetic acid has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 2 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Research Excerpts

ExcerptRelevanceReference
"Patients with chronic fatigue syndrome showed a significant reduction in basal plasma levels of MHPG and a significant increase in basal plasma levels of 5-HIAA."1.28Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. ( Dale, JK; Demitrack, MA; Gold, PW; Kling, MA; Krahn, DD; Straus, SE, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Thakur, V1
Jamwal, S1
Kumar, M1
Rahi, V1
Kumar, P1
Demitrack, MA1
Gold, PW1
Dale, JK1
Krahn, DD1
Kling, MA1
Straus, SE1

Other Studies

2 other studies available for hydroxyindoleacetic acid and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Protective Effect of Hemin Against Experimental Chronic Fatigue Syndrome in Mice: Possible Role of Neurotransmitters.
    Neurotoxicity research, 2020, Volume: 38, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Behavior, Animal; Brain; Disease Models, Animal; D

2020
Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings.
    Biological psychiatry, 1992, Dec-15, Volume: 32, Issue:12

    Topics: Adult; Anxiety Disorders; Blood-Brain Barrier; Cohort Studies; Depressive Disorder; Fatigue Syndrome

1992